骨转移姑息放疗临床试验终点国际共识:第二次更新
国际骨转移共识工作组采用改良Delphi流程,结合系统文献综述与2012年后指南,对骨转移姑息性体外放疗(EBRT)临床试验终点进行第二次更新。125名受邀专家中58人参与第一阶段、44人参与第二阶段,49条陈述中38条达成共识(78%),含18条新增或修订条目,覆盖入组标准、疼痛与镇痛评估、放疗技术与剂量方案、随访及成本效果分析等。
要点
- 49条陈述中38条达成共识(78%),含18条新增或修订条目。
- 共识覆盖入组标准、疼痛与镇痛评估、放疗技术与剂量方案及随访。
- 建议将成本效果分析纳入骨转移EBRT临床试验设计与报告。
核心结论
- 该更新共识为骨转移EBRT试验设计与报告提供当代标准化框架,采纳后可提高跨研究可比性并指导未来研究重点。
研究设计与样本
- 采用改良Delphi流程,以系统文献综述和2012年后指南出版物为依据,并通过电子调查征询既往贡献者与国际公认骨EBRT专家。
- 第一阶段125名受邀专家中58人参与,达成≥75%一致性的陈述被接受;未达共识条目经工作组完善、8人核心专家组讨论后于第二阶段重新征询,44人参与。
主要发现
- 49条陈述中38条达成共识(78%),其中18条为新增或修订条目。
- 共识涉及试验入组资格标准、标准化疼痛与镇痛评估、放疗技术与剂量方案、随访间隔、评估时机与方式以及成本效果分析。
关键数值与推荐
- 第一阶段以陈述达成≥75%一致性作为接受标准。
- 49条陈述中38条达成共识(78%),包含18条新增或修订条目。
临床怎么用
- 骨转移姑息EBRT临床试验设计及报告可采用该共识框架统一入组标准、疼痛与镇痛评估、放疗技术与剂量方案及随访安排。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: External beam radiotherapy (EBRT) is a well-established and effective intervention for pain palliation in patients with bone metastases. Variability in trial endpoints, however, has limited comparability and synthesis of available evidence. To address this, the International Bone Metastases Consensus Working Party published endpoint guidelines in 2002 and updated them in 2012. This study aims to review, re-evaluate, and update the existing consensus to reflect contemporary clinical practice and technological advances. MATERIALS AND METHODS: A modified Delphi process was undertaken, informed by a systematic literature review and post-2012 guideline publications. An electronic survey was distributed to previous contributors and internationally recognized bone EBRT experts. In Phase I, statements achieving ≥ 75 % agreement were accepted. Items not reaching consensus were refined by the Working Party, discussed by a core panel of eight experts, and recirculated in Phase II. Descriptive statistics summarized response rates and agreement levels. RESULTS: Of 125 experts invited, 58 participated in Phase I, and 44 in Phase II. Consensus was achieved for 38 out of 49 statements (78%), including 18 new or revised items. Key recommendations addressed eligibility criteria for trial enrolment, standardized pain and analgesic assessments, specification of radiation techniques and dose schedules, follow-up intervals, assessment timing and modalities, and incorporation of cost-effectiveness analyses. CONCLUSION: This updated consensus provides a contemporary, standardized framework for EBRT trial design and reporting in bone metastases. Adoption will improve cross-study comparability and guide future research priorities. Regular updates are planned to ensure alignment with evolving clinical practice and technology.
引用
- Oldenburger E, Jomy J, Navarro-Domenech I, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases: A second update. Radiother Oncol. 2025. PMID: 41285182. doi:10.1016/j.radonc.2025.111300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。